investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Post-Vacc. Hpv Genotype Distr. Among HIV+ and HIV- Young Women in S. Africa
David H Adler
3 Collaborator(s)
Funding source
National Institute of Allergy and Infectious Diseases (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Guy De Bruyn
University of the Witwatersrand
Johannesburg, South Africa
Notando G Moeketsi
University of Limpopo
Polokwane, South Africa
Linda Gail
Desmond Tutu HIV Foundation
Cape Town, South Africa
David H Adler
University of Rochester
Rochester, United States
Related projects
Global Noncommunicable Diseases Intiatives
Improving data for global cervical cancer screening and treatment programs
Cervix uteri
Kathleen Schmeler
Conservative Surgery for Women with Low-Risk, Early Stage Cervical Cancer
Cervix uteri
Surgery / Surgical oncology
Global Noncommunicable Diseases Intiatives
Preventing women from cervical cancer/Gynecological Examination and Diagnosis - 2
Cervix uteri
Global Noncommunicable Diseases Intiatives
Cervical cancer prevention: Sharing best practices and critical data and expanding screening capacity - 2
Cervix uteri
Global Noncommunicable Diseases Intiatives
Cervical cancer prevention: Sharing best practices and critical data and expanding screening capacity
Cervix uteri
Miriam Cremer
CryoPen: An Innovative Treatment for Cervical Precancer in Low-Resource Setting
Cervix uteri
Mark H. Einstein
Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
Cervix uteri
Global Noncommunicable Diseases Intiatives
Scientific evidence for the design of a policy for vaccines introduction against HPV in the female population of Bolivia.
Cervix uteri
Julie McElrath
Cape Town HVTN Immunology Laboratory
Cervix uteri
